Esophageal cancer has been the subject of sustained clinical investigation across multiple research sites.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID	Title	Status	Phase
NCT00054457	Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction	COMPLETED	PHASE2
NCT00052910	Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer	COMPLETED	PHASE3
NCT00938470	Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction	COMPLETED	PHASE2
NCT00109850	S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer	TERMINATED	PHASE2
NCT00381706	Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	COMPLETED	PHASE2
NCT00551759	Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer	TERMINATED	PHASE2
NCT00022139	Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction	COMPLETED	PHASE2
NCT00096031	S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer	COMPLETED	PHASE2
NCT01498289	S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer	COMPLETED	PHASE2
NCT00086996	S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction	COMPLETED	PHASE2

Related Pages

All Esophageal cancer trials All trials in Dodge City, United States